This biotech stock can rally more than 70% with its fatty liver disease treatment, UBS says

Norge Nyheter Nyheter

This biotech stock can rally more than 70% with its fatty liver disease treatment, UBS says
Norge Siste Nytt,Norge Overskrifter
  • 📰 CNBC
  • ⏱ Reading Time:
  • 5 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 5%
  • Publisher: 72%

Analyst Eliana Merle initiated the clinical-stage company with a buy rating and assigned a price target of $83, implying shares stand to gain 73%.

Akero Therapeutics could be a winner in the race to treat non-alcoholic steatohepatitis, a potentially life-threatening liver disease. Analyst Eliana Merle initiated the clinical-stage company with a buy rating and assigned a price target of $83, implying shares stand to gain 73% in the next 12 months. Akero develops treatments for patients with serious metabolic disease, including a therapy called efruxifermin , which received Breakthrough Therapy Designation from the U.S.

mountain Akero Therapeutics stock. — CNBC's Michael Bloom contributed reporting.

Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

CNBC /  🏆 12. in US

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

I-70 through Glenwood Canyon closed for flash flood warningI-70 through Glenwood Canyon closed for flash flood warningBoth directions of Interstate 70 through Glenwood Canyon are closed after the Colorado Department of Transportation shut the interstate down Saturday due to a flash flood warning.
Les mer »

Heavy rain, flash flood shuts down I-70 through Glenwood CanyonHeavy rain, flash flood shuts down I-70 through Glenwood CanyonInterstate 70 through Glenwood Canyon is shut down in both directions by a flash flood, Colorado Department of Transportation said.
Les mer »

Swiss Competition Commission examining UBS takeover of Credit SuisseSwiss Competition Commission examining UBS takeover of Credit SuisseSwiss Competition Commission examining UBS takeover of Credit Suisse - media
Les mer »

5 Huge Analyst Calls: Netflix Grabs Another Buy Call; Dick's Slashed at BofA5 Huge Analyst Calls: Netflix Grabs Another Buy Call; Dick's Slashed at BofAStocks Analysis by Investing.com (Garrett Cook) covering: Netflix Inc, Medical Properties Trust Inc, Dick’s Sporting Goods Inc, Fulcrum Therapeutics Inc. Read Investing.com (Garrett Cook)'s latest article on Investing.com
Les mer »

China’s Debt Problm Could Trigger a Financial Crisis, Analyst SaysChina’s Debt Problm Could Trigger a Financial Crisis, Analyst SaysCharlene Chu, senior analyst at Autonomous Research, talks to Barron's about China’s ailing economy, high debt, troubled real-estate market, and opaque...
Les mer »

Social Security Update: Direct payment worth up to $4,555 goes out to millions in 18 daysSocial Security Update: Direct payment worth up to $4,555 goes out to millions in 18 daysMillions of retirees will receive their first September retirement checks from Social Security, which are worth up to $4,555 for seniors who are at least 70, in 18 days.
Les mer »



Render Time: 2025-03-06 06:49:42